Medical News

RSS

Abiomed first quarter fiscal 2012 revenue up 25% to $27.4 million

Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2012 revenue of $27.4 million, up 25% compared to revenue of $22.0 million in the same period of fiscal 2011.

4 Aug 2011

Canadian physicians spend less on health insurance administrative costs than U.S. doctors

U.S. physicians spend nearly $61,000 more than their Canadian counterparts each year on administrative expenses related to health insurance, according to a new study by researchers at Cornell University and the University of Toronto.

4 Aug 2011

ArQule second quarter net loss increases to $10,804,000

ArQule, Inc. today announced its financial results for the second quarter of 2011.

4 Aug 2011

Safe Kids USA to host Youth Sports Safety Clinics

With many young school athletes working hard this month to prepare for fall sports, Safe Kids USA is hosting Youth Sports Safety Clinics across the country to educate parents and coaches on how to keep children safe and prevent sports injuries, including heat-related illnesses. Nearly 3/4 of U.S. households have at least one child who plays organized sports.

4 Aug 2011

Health Care REIT second quarter normalized FFO up 13% to $0.90 per share

Health Care REIT, Inc. today announced operating results for the company's second quarter ended June 30, 2011.

4 Aug 2011

Hundreds of parents in Nigerian state refusing polio vaccinations for children

Hundreds of parents "are defying threats of jail time by refusing polio vaccines for their children in a high-risk northern Nigerian state," according to Muhammad Abdu Zango, Kano state coordinator of Journalists Against Polio, the Associated Press/Seattle Times reports.

4 Aug 2011

MOCON second quarter net sales increase 24% to $9,082,000

MOCON, Inc. today reported its operating results for the second quarter ended June 30, 2011.

4 Aug 2011

Valeant second quarter total revenue increases to record $609.4 million

Valeant Pharmaceuticals International, Inc. announces second quarter financial results for 2011.

4 Aug 2011

First Edition: August 4, 2011

In today's news, reports about how lawmakers, lobbyists are lining up for the next phase of the deficit deal.

4 Aug 2011

Dyax initiates ecallantide Phase 2 trial for ACE inhibitor-induced angioedema

Dyax Corp. announced today treatment of the first patient in a Phase 2 trial evaluating the efficacy and safety of ecallantide, a potent, selective, reversible inhibitor of plasma kallikrein, for acute treatment of angiotensin converting enzyme (ACE) inhibitor-induced angioedema.

4 Aug 2011

Palatin confirms initiation of AZD2820 Phase 1 trial in obesity

Palatin Technologies, Inc. confirmed today the commencement of a Phase 1 clinical trial of AZD2820, a subcutaneously-administered peptide melanocortin receptor partial agonist, under development as a single-agent therapy for the treatment of obesity.

4 Aug 2011

Health Net second quarter total revenues decrease 19.2% to $2.8 billion

Health Net, Inc. today announced 2011 second quarter GAAP net income of $58.3 million, or $0.63 per diluted share, compared with $45.1 million, or $0.45 per diluted share, for the second quarter of 2010.

4 Aug 2011

RNAi screen identifies Brd4 as a therapeutic target for acute myeloid leukemia

Scientists at Cold Spring Harbor Laboratory (CSHL) and five other institutions have used an unconventional approach to cancer drug discovery to identify a new potential treatment for acute myeloid leukemia.

4 Aug 2011

Micromet second quarter total revenues increase to $7.1 million

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced its financial results for the second quarter and six months ended June 30, 2011.

4 Aug 2011

Boston Therapeutics files chewable metformin ANDA with FDA to treat diabetes

Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, today announced that it has submitted an Abbreviated New Drug Application (ANDA) for chewable metformin with the U.S. Food and Drug Administration.

4 Aug 2011

Transcend second quarter revenue increases 38% to $30,662,000

Transcend Services, Inc., a leading provider of clinical documentation solutions to the U.S. healthcare market, today announced its unaudited financial results for the second quarter ended June 30, 2011.

4 Aug 2011

Scientists say antibiotic-resistant salmonella strain may spread worldwide

"Scientists have identified an emerging 'superbug' strain of salmonella that is highly resistant to the antibiotic Ciprofloxacin, or Cipro, often used for severe salmonella infections, and say they fear it may spread around the world," according to a study published online Tuesday in the Journal of Infectious Diseases, Reuters reports.

4 Aug 2011

NanoString to begin clinical development program for Breast Cancer Intrinsic Subtyping Assay

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it is initiating the first in a series of studies to evaluate the clinical utility of the NanoString Breast Cancer Intrinsic Subtyping Assay.

From NanoString Technologies 4 Aug 2011

SXC second quarter revenue increases 153% to $1.2 billion

SXC Health Solutions Corp., a leading provider of technology and pharmacy benefit management services, announces its financial results for the three-month and six-month periods ended June 30, 2011.

4 Aug 2011